Lonza today announced the expansion of its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in North America. The company will install a new Harro ...
The newly installed Harro Hӧfliger encapsulation unit expands Capsugel’s clinical- and commercial-scale capacity for dry powder inhalation projects. Capsugel has expanded its late-stage inhalation ...
A new suite for the encapsulation of highly potent drugs will be added. Lonza announced on Feb. 20, 2018 that it is expanding its late-stage clinical and commercial encapsulation capabilities for ...